Rehabilitation Research Center, Department of Physical Therapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.
Bethesda Physiocare, Bethesda, Maryland, USA.
Phys Ther. 2021 May 4;101(5). doi: 10.1093/ptj/pzab068.
Dry needling is a treatment technique used by clinicians to relieve symptoms in patients with tension-type headache (TTH), cervicogenic headache (CGH), or migraine. This systematic review's main objective was to assess the effectiveness of dry needling on headache pain intensity and related disability in patients with TTH, CGH, or migraine.
Medline/PubMed, Scopus, Embase, PEDro, Web of Science, Ovid, Allied and Complementary Medicine Database/EBSCO, Cochrane Central Register of Controlled Clinical Trials, Google Scholar, and trial registries were searched until April 1, 2020, along with reference lists of eligible studies and related reviews. Randomized clinical trials or observational studies that compared the effectiveness of dry needling with any other interventions were eligible for inclusion. Three reviewers independently selected studies, extracted data, and assessed risk of bias. Random-effects meta-analyses were performed to produce pooled-effect estimates (Morris dppc2) and their respective CIs.
Of 2715 identified studies, 11 randomized clinical trials were eligible for qualitative synthesis and 9 for meta-analysis. Only 4 trials were of high quality. Very low-quality evidence suggested that dry needling is not statistically better than other interventions for improving headache pain intensity in the short term in patients with TTH (SMD -1.27, 95% CI = -3.56 to 1.03, n = 230), CGH (SMD -0.41, 95% CI = -4.69 to 3.87, n = 104), or mixed headache (TTH and migraine; SMD 0.03; 95% CI = -0.42 to 0.48, n = 90). Dry needling provided significantly greater improvement in related disability in the short term in patients with TTH (SMD -2.28, 95% CI = -2.66 to -1.91, n = 160) and CGH (SMD -0.72, 95% CI = -1.09 to -0.34, n = 144). The synthesis of results showed that dry needling could significantly improve headache frequency, health-related quality of life, trigger point tenderness, and cervical range of motion in TTH and CGH.
Dry needling produces similar effects to other interventions for short-term headache pain relief, whereas dry needling seems to be better than other therapies for improvement in related disability in the short term.
Although further high-methodological quality studies are warranted to provide a more robust conclusion, our systematic review suggested that for every 1 or 2 patients with TTH treated by dry needling, 1 patient will likely show decreased headache intensity (number needed to treat [NNT] = 2; large effect) and improved related disability (NNT = 1; very large effect). In CGH, for every 3 or 4 patients treated by dry needling, 1 patient will likely exhibit decreased headache intensity (NNT = 4; small effect) and improved related disability (NNT = 3; medium effect).
干针疗法是一种由临床医生用于缓解紧张型头痛(TTH)、颈源性头痛(CGH)或偏头痛患者症状的治疗技术。本系统评价的主要目的是评估干针疗法对 TTH、CGH 或偏头痛患者头痛疼痛强度和相关残疾的疗效。
检索了 Medline/PubMed、Scopus、Embase、PEDro、Web of Science、Ovid、 Allied and Complementary Medicine Database/EBSCO、Cochrane 中央对照临床试验注册中心、Google Scholar 和试验注册处,检索时间截至 2020 年 4 月 1 日,并查阅了合格研究的参考文献列表和相关综述。纳入了比较干针疗法与任何其他干预措施有效性的随机临床试验或观察性研究。三位评审员独立选择研究、提取数据并评估偏倚风险。采用随机效应荟萃分析生成汇总效应估计值(Morris dppc2)及其相应的置信区间(CI)。
在 2715 项确定的研究中,有 11 项随机临床试验适合进行定性综合分析,9 项适合进行荟萃分析。只有 4 项试验质量较高。低质量证据表明,在 TTH 患者中,干针疗法在短期内改善头痛疼痛强度的效果并不优于其他干预措施(SMD-1.27,95%CI=-3.56 至 1.03,n=230)、CGH(SMD-0.41,95%CI=-4.69 至 3.87,n=104)或混合性头痛(TTH 和偏头痛;SMD 0.03;95%CI=-0.42 至 0.48,n=90)。干针疗法在短期内对 TTH 和 CGH 患者的相关残疾有显著改善(SMD-2.28,95%CI=-2.66 至-1.91,n=160)和 CGH(SMD-0.72,95%CI=-1.09 至-0.34,n=144)。结果综合表明,干针疗法可显著改善 TTH 和 CGH 患者的头痛发作频率、健康相关生活质量、激痛点压痛和颈椎活动度。
干针疗法在短期内与其他干预措施缓解头痛疼痛的效果相似,而干针疗法在短期内改善相关残疾方面似乎优于其他疗法。
尽管需要进一步进行方法学质量较高的研究以提供更可靠的结论,但我们的系统评价表明,对于每 1 或 2 例接受干针治疗的 TTH 患者,有 1 例患者的头痛强度可能会降低(需要治疗的人数[NNT]=2;大效应),相关残疾也会改善(NNT=1;非常大效应)。在 CGH 中,每 3 或 4 例接受干针治疗的患者中,有 1 例患者的头痛强度可能会降低(NNT=4;小效应),相关残疾也会改善(NNT=3;中效应)。